Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 16.

Cusini, A; Béguelin, C; Stampf, S; Boggian, K; Garzoni, C; Koller, M; Manuel, O; Meylan, P; Mueller, N J; Hirsch, H H; Weisser, M; Berger, C; van Delden, C; Swiss Transplant Cohort Study (2018). Clostridium difficile infection is associated with graft loss in solid organ transplant recipients. American Journal of Transplantation, 18(7):1745-1754.

Leboeuf, C; Wilk, S; Achermann, R; Binet, I; Golshayan, D; Hadaya, K; Hirzel, C; Hoffmann, M; Huynh-Do, U; Koller, M T; Manuel, O; Mueller, N J; Mueller, T F; Schaub, Stefan; van Delden, C; Weissbach, F H; Hirsch, H H; Swiss Transplant Cohort Study (2017). BK polyomavirus-specific 9mer CD8 T cell responses correlate with clearance of BK viremia in kidney transplant recipients: first report from the Swiss Transplant Cohort Study. American Journal of Transplantation, 17(10):2591-2600.

Han, Sang Hoon; Kumar, D; Ferreira, V H; Egli, A; Hirsch, H H; Weisser, M; Garzoni, C; van Delden, C; Bochud, P Y; Manuel, O; Meylan, P; Boggian, K; Husain, S; Mueller, N J; Humar, A; Swiss Transplant Cohort Study (2017). Human microRNA responses predict cytomegalovirus replication following solid organ transplantation. Journal of Infectious Diseases, 215(4):537-546.

Wiesmann, F; Naeth, G; Berger, A; Hirsch, H H; Regenass, S; Ross, R S; Sarrazin, C; Wedemeyer, H; Knechten, H; Braun, P (2016). Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment. Medical Microbiology and Immunology, 205(3):263-268.

Gonzalez, A; Schmitter, K; Hirsch, H H; Garzoni, C; van Delden, C; Boggian, K; Mueller, N J; Berger, C; Villard, J; Manuel, O; Meylan, P; Stern, M; Hess, C (2014). KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients. Genes and immunity, 15(7):495-499.

Manuel, O; Kralidis, G; Mueller, N J; Hirsch, H H; Garzoni, C; van Delden, C; Berger, C; Boggian, K; Cusini, A; Koller, M T; Weisser, M; Pascual, M; Meylan, P R (2013). Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients. American Journal of Transplantation, 13(9):2402-2410.

El Amari, E B; Combescure, C; Yerly, S; Calmy, A; Kaiser, L; Hasse, B; Furrer, H; Cavassini, M; Vernazza, P; Hirsch, H H; Bernasconi, E; Hirschel, B (2011). Clinical relevance of cytomegalovirus viraemia(*,†). HIV Medicine, 12(7):394-402.

Fehr, J; Glass, T R; Louvel, S; Hamy, F; Hirsch, H H; von Wyl, V; Böni, J; Yerly, S; Bürgisser, P; Cavassini, M; Fux, C A; Hirschel, B; Vernazza, P; Martinetti, G; Bernasconi, E; Günthard, H F; Battegay, M; Bucher, H C; Klimkait, T (2011). Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study. Journal of Translational Medicine, 9:14.

Fritzsche, F R; Pianca, S; Gaspert, A; Varga, Z; Wang, L; Farrell, M P; Chen, X B; Hirsch, H H; Springer, E; Fehr, T; Myles, J; Tubbs, R; Moch, H (2011). Silver-enhanced in situ hybridization for detection of polyomavirus DNA in patients with BK virus nephropathy. Diagnostic Molecular Pathology, 20(2):105-110.

Sullivan, S G; Hirsch, H H; Franceschi, S; Steffen, I; Amari, E B E; Mueller, N J; Magkouras, I; Biggar, R J; Rickenbach, M; Clifford, G M (2010). Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study. AIDS, 24(14):2245-2252.

Nickel, C H; Stephan, F P; Dangel, M; Blume, K; Gehrisch, R; Dumoulin, A; Tschudin, S; Keller, D I; Hirsch, H H; Widmer, A F; Bingisser, R (2009). First wave of the influenza A/H1N1v pandemic in Switzerland. Swiss Medical Weekly, 139(51-52):731-737.

Provenzano, M; Sais, G; Bracci, L; Egli, A; Anselmi, M; Viehl, C T; Schaub, S; Hirsch, H H; Stroncek, D F; Marincola, F M; Spagnoli, G C (2009). A HCMV pp65 polypeptide promotes the expansion of CD4+ and CD8+ T cells across a wide range of HLA specificities. Journal of Cellular and Molecular Medicine, 13(8b):2131-2147.

Khanna, N; Elzi, L; Mueller, N J; Garzoni, C; Cavassini, M; Fux, C A; Vernazza, P; Bernasconi, E; Battegay, M; Hirsch, H H (2009). Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clinical Infectious Diseases, 48(10):1459-1466.

Khanna, N; Wolbers, M; Mueller, N J; Garzoni, C; Du Pasquier, R A; Fux, C A; Vernazza, P; Bernasconi, E; Viscidi, R; Battegay, M; Hirsch, H H (2009). JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. Journal of Virology, 83(9):4404-4411.

El Amari, E B; Toutous-Trellu, L; Gayet-Ageron, A; Baumann, M; Cathomas, G; Steffen, I; Erb, P; Mueller, N J; Furrer, H; Cavassini, M; Vernazza, P; Hirsch, H H; Bernasconi, E; Hirschel, B (2008). Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. AIDS, 22(9):1019-1028.

Egli, A; Bergamin, O; Müllhaupt, B; Seebach, J D; Mueller, N J; Hirsch, H H (2008). Cytomegalovirus-associated chorioretinitis after liver transplantation: case report and review of the literature. Transplant Infectious Disease, 10(1):27-43.

This list was generated on Mon Jul 16 20:48:58 2018 CEST.